// App-Quantinova.ai

51 : Combined DNA-methylation intensity and clinical risk score to stratify patients for high-grade disease.

Researchers

Presenter

  • Leander Van Neste

Principal Investigators

  • Grant Stewart

  • Sandra Marlene Gaston

  • William E. Grizzle

  • George W. Adams

  • Gary P Kearney

  • Jonathan I Epstein

  • David James Harrison

  • Alan W. Partin

  • Wim Van Criekinge

Medical Centers

  • Maastricht University Medical Center, Maastricht, Netherlands

  • Tufts Medical Center, Boston, MA

  • Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL

  • Urology Centers of Alabama, Urology, Homewood, AL

  • New England Baptist Hosp, Boston, MA

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • University of St. Andrews School of Medicine, St. Andrews, United Kingdom

  • The Johns Hopkins Hospital, Baltimore, MD

  • University Hospital Gent, Gent, Belgium

Locations

  • Netherlands

  • United Kingdom

  • United States

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Adenomatous Polyposis Coli

  • Ras Association Domain Family Member 1

  • Glutathione S-transferase P1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved